HTR2A and metabolic dysfunction-associated steatotic liver disease: As the increase in 5-HT upregulates HTR2A and HTR2B expression in hepatocytes (Li et al., 2018), HTR activation is also expected to increase to mirror 5-HT increase in NAFLD and PH models.